Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stavros Mountantonakis

Clinical Cardiac Electrophysiology Manhasset, NY Medical Doctor

NPI 1114153731 CMS profile 50534

300 Community Dr, Cardiology, Manhasset, NY 11030

Open in the dashboard

General payments

$320,793

614 records reported · program years 2019–2025

Research payments

$26,285

Paid to them · 6 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,273,339 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Stavros Mountantonakis of Manhasset, NY is reported in the CMS Open Payments database as having received $320,793 across 614 general payments and $26,285 in research payments paid to them. Separately, studies naming them as principal investigator received $2,273,339 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $114,076 207
2025 Research $24,935 4
2024 General $70,512 120
2024 Research $525 1
2023 General $30,169 84
2022 General $46,104 69
2022 Research $825 1
2021 General $20,433 54
2020 General $3,568 8
2019 General $35,933 72

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stavros Mountantonakis
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Stavros Mountantonakis were reported at $114,076. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Stavros Mountantonakis Clinical Cardiac Electrophysiology median Middle half National median
2019 $35,933 $2,361 $585–$8,260 $163
2020 $3,568 $993 $247–$4,351 $114
2021 $20,433 $1,185 $326–$4,739 $132
2022 $46,104 $2,073 $554–$6,789 $149
2023 $30,169 $2,568 $759–$8,159 $160
2024 $70,512 $2,557 $703–$7,403 $164
2025 $114,076 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $106,036 200 payments
  2. Biotronik Inc. $58,585 162 payments
  3. Volta Medical Inc $27,872 17 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $27,000 15 payments
  5. Medtronic Vascular, Inc. $25,868 43 payments
  6. Biosense Webster, Inc. $23,109 45 payments
  7. Boston Scientific Corporation $19,569 35 payments
  8. Abbott Laboratories $12,121 61 payments
  9. Ge Healthcare $11,550 4 payments
  10. Medical Device Business Services, Inc. $6,132 1 payment
  11. Other $2,950 31 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $109,689 35 payments
  2. Travel and Lodging $61,804 123 payments
  3. Consulting Fee $58,965 22 payments
  4. Food and Beverage $31,168 392 payments
  5. Honoraria $27,000 15 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $21,295 18 payments
  7. Grant $7,222 2 payments
  8. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,200 2 payments
  9. Education $451 5 payments
Products named General payments · program years 2019–2025
  1. LifeVest $27,000 15 payments
  2. VX1 $24,872 11 payments
  3. Carto 3 $22,673 35 payments
  4. Arctic Front $16,548 28 payments
  5. BioMonitor $16,094 37 payments
  6. Solia $15,784 33 payments
  7. Edora 8 DR-T $12,263 4 payments
  8. Acticor 7 VR-T DX $12,152 4 payments
  9. Rivacor 7 DR-T $12,061 2 payments
  10. Acticor $11,731 37 payments
  11. Other $84,482 337 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Biotronik Inc. $15,404 3 payments
  2. Abbott Laboratories $10,356 2 payments
  3. Medtronic, Inc. $525 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

56

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$20,729

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

35.7%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 20 $20,330
Metoprolol Succinate Generic 36 $399

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$218,135

Medicare's payments for the services billed

Medicare patients

546

Average age 78

Services billed

2,725

247 women, 299 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 68%
Arthritis 52%
Ischemic heart disease 51%
Heart failure 44%
Diabetes 37%
Chronic kidney disease 29%
Depression 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

620 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record